Johnson & Johnson CEO and Chairman Joaquin Duato sold 20,976 shares on Aug. 13, 2026, at $262.00 per share, for a total of about $5.50 million. Trades by the CEO and board chair tend to draw attention because this role typically has broad visibility into the company’s operations, strategy, and risks, making the timing and size of any sale more notable than trades by lower-level executives. That said, insider sales are often a weaker signal than insider buys because they can be driven by personal financial planning, taxes, or diversification rather than a view on the business. This sale was not reported as being made under a pre-scheduled Rule 10b5-1 trading plan, which can make it more relevant to investors because it wasn’t automatically scheduled far in advance. Even so, without details such as how many shares Duato still holds, whether this was tied to option exercises, or whether it aligns with a regular selling cadence, the informational value is limited. Over the past 30 days, the only disclosed transaction in the provided data is this sale by Duato. Investors typically watch whether additional insiders sell in a short window or whether repeated sales by the same executive become a pattern that meaningfully reduces ownership.